SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3ldo'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GFZ_A_CFFA940_1 (GLYCOGEN PHOSPHORYLASE)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.09A	1gfzA-3ldoA: undetectable	1gfzA-3ldoA: 18.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIA_B_SAMB1293_1 (GLYCINE N-METHYLTRANSFERASE)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 5	ARG A 261 ASP A 250 ASN A 248 SER A 337	None	1.14A	1kiaB-3ldoA: undetectable	1kiaB-3ldoA: 21.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KIA_C_SAMC2293_1 (GLYCINE N-METHYLTRANSFERASE)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ARG A 261 ASP A 250 ASN A 248 SER A 337	None	1.16A	1kiaC-3ldoA: undetectable	1kiaC-3ldoA: 21.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L5Q_A_CFFA863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.10A	1l5qA-3ldoA: undetectable	1l5qA-3ldoA: 18.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L7X_A_CFFA863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.06A	1l7xA-3ldoA: undetectable	1l7xA-3ldoA: 18.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L7X_B_CFFB1863_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.09A	1l7xB-3ldoA: undetectable	1l7xB-3ldoA: 18.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NBH_B_SAMB1293_1 (GLYCINE N-METHYLTRANSFERASE)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 5	ARG A 261 ASP A 250 ASN A 248 SER A 337	None	1.14A	1nbhB-3ldoA: 1.2	1nbhB-3ldoA: 21.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RJD_B_SAMB802_0 (CARBOXY METHYL TRANSFERASE FOR PROTEIN PHOSPHATASE 2A CATALYTIC SUBUNIT)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 12	ILE A 371 GLY A 254 GLY A 227 LEU A 334 LEU A 253	None None ANP A 408 (-3.4A) None None	1.10A	1rjdB-3ldoA: undetectable	1rjdB-3ldoA: 21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RJD_C_SAMC803_0 (CARBOXY METHYL TRANSFERASE FOR PROTEIN PHOSPHATASE 2A CATALYTIC SUBUNIT)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 12	ILE A 371 GLY A 254 GLY A 227 LEU A 334 LEU A 253	None None ANP A 408 (-3.4A) None None	1.09A	1rjdC-3ldoA: undetectable	1rjdC-3ldoA: 21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2AVV_A_MK1A901_2 (POL POLYPROTEIN)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	3 / 3	ASP A 357 VAL A 360 PRO A 202	None	0.74A	2avvA-3ldoA: undetectable	2avvA-3ldoA: 15.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PIW_A_T3A932_1 (ANDROGEN RECEPTOR)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	LEU A 98 VAL A 108 ILE A 112 ILE A 128	None	0.86A	2piwA-3ldoA: undetectable	2piwA-3ldoA: 20.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Q6O_B_SAMB500_0 (HYPOTHETICAL PROTEIN)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASP A 224 VAL A 362 PRO A 173 THR A 171	None	1.27A	2q6oB-3ldoA: undetectable	2q6oB-3ldoA: 23.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BCR_A_AZZA940_1 (GLYCOGEN PHOSPHORYLASE, MUSCLE FORM)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 5	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.14A	3bcrA-3ldoA: undetectable	3bcrA-3ldoA: 18.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DD1_A_CFFA903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.12A	3dd1A-3ldoA: undetectable	3dd1A-3ldoA: 18.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DD1_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.09A	3dd1B-3ldoA: undetectable	3dd1B-3ldoA: 18.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDS_A_CFFA904_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.11A	3ddsA-3ldoA: undetectable	3ddsA-3ldoA: 18.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDS_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.09A	3ddsB-3ldoA: undetectable	3ddsB-3ldoA: 18.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDW_A_CFFA903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.12A	3ddwA-3ldoA: undetectable	3ddwA-3ldoA: 18.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DDW_B_CFFB903_1 (GLYCOGEN PHOSPHORYLASE, LIVER FORM)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	ASN A 177 PHE A 176 ALA A 179 GLY A 100	None	1.11A	3ddwB-3ldoA: undetectable	3ddwB-3ldoA: 18.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HUO_B_PNNB301_0 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 12	GLY A 363 GLY A 364 GLY A 255 ASP A 257 ARG A 297	ANP A 408 (-3.2A) ANP A 408 (-3.1A) ANP A 408 (-3.4A) None None	0.98A	3huoB-3ldoA: undetectable	3huoB-3ldoA: 22.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W9T_D_W9TD507_1 (HEMOLYTIC LECTIN CEL-III)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 5	ASP A 257 GLU A 256 GLY A 228 ASP A 250	None None ANP A 408 (-3.6A) None	1.39A	3w9tD-3ldoA: undetectable	3w9tD-3ldoA: 20.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W9T_D_W9TD507_1 (HEMOLYTIC LECTIN CEL-III)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 5	GLU A 316 GLY A 315 TYR A 313 ASP A 281	None	1.20A	3w9tD-3ldoA: undetectable	3w9tD-3ldoA: 20.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4K50_A_ACTA506_0 (RNA POLYMERASE 3D-POL)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	3 / 3	VAL A 66 GLY A 77 LYS A 81	None	0.73A	4k50A-3ldoA: undetectable	4k50A-3ldoA: 22.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4K50_I_ACTI504_0 (RNA POLYMERASE 3D-POL)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	3 / 3	VAL A 66 GLY A 77 LYS A 81	None	0.71A	4k50I-3ldoA: undetectable	4k50I-3ldoA: 22.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4MM4_B_8PRB603_1 (TRANSPORTER)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 12	ASP A 231 ALA A 206 VAL A 360 SER A 233 THR A 171	None	1.13A	4mm4B-3ldoA: undetectable	4mm4B-3ldoA: 21.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OKW_A_198A1001_1 (ANDROGEN RECEPTOR)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 12	GLY A 58 ARG A 290 THR A 156 ILE A 53 VAL A 42	None	1.34A	4okwA-3ldoA: undetectable	4okwA-3ldoA: 19.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QWP_B_GCSB307_1 (CHITOSANASE)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 7	GLU A 201 THR A 37 GLY A 36 THR A 38	None ANP A 408 (-3.4A) ANP A 408 (-3.2A) ANP A 408 (-2.8A)	0.95A	4qwpB-3ldoA: undetectable	4qwpB-3ldoA: 23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Z4G_A_IPHA903_0 (PROTEIN ARGONAUTE-2)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 6	LEU A 98 LYS A 125 PRO A 126 GLU A 143	None	1.14A	4z4gA-3ldoA: 6.4	4z4gA-3ldoA: 18.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AQF_A_ADNA1382_1 (HEAT SHOCK COGNATE 71 KDA PROTEIN)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	7 / 10	GLY A 226 GLY A 255 LYS A 296 SER A 300 GLY A 364 SER A 365 ILE A 368	ANP A 408 (-3.4A) ANP A 408 (-3.4A) ANP A 408 (-3.1A) ANP A 408 (-2.6A) ANP A 408 (-3.1A) ANP A 408 (-3.9A) ANP A 408 (-4.8A)	1.04A	5aqfA-3ldoA: 53.7	5aqfA-3ldoA: 69.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AQF_A_ADNA1382_1 (HEAT SHOCK COGNATE 71 KDA PROTEIN)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	7 / 10	GLY A 226 GLY A 255 LYS A 296 SER A 300 SER A 365 ARG A 367 ILE A 368	ANP A 408 (-3.4A) ANP A 408 (-3.4A) ANP A 408 (-3.1A) ANP A 408 (-2.6A) ANP A 408 (-3.9A) ANP A 408 (-4.9A) ANP A 408 (-4.8A)	1.14A	5aqfA-3ldoA: 53.7	5aqfA-3ldoA: 69.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AQF_A_ADNA1382_1 (HEAT SHOCK COGNATE 71 KDA PROTEIN)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	8 / 10	GLY A 227 GLY A 255 GLU A 293 LYS A 296 SER A 300 GLY A 364 SER A 365 ILE A 368	ANP A 408 (-3.4A) ANP A 408 (-3.4A) ANP A 408 (-2.5A) ANP A 408 (-3.1A) ANP A 408 (-2.6A) ANP A 408 (-3.1A) ANP A 408 (-3.9A) ANP A 408 (-4.8A)	0.52A	5aqfA-3ldoA: 53.7	5aqfA-3ldoA: 69.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AQF_A_ADNA1382_1 (HEAT SHOCK COGNATE 71 KDA PROTEIN)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 10	GLY A 227 GLY A 255 GLY A 364 SER A 365 ILE A 371	ANP A 408 (-3.4A) ANP A 408 (-3.4A) ANP A 408 (-3.1A) ANP A 408 (-3.9A) None	0.99A	5aqfA-3ldoA: 53.7	5aqfA-3ldoA: 69.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AQF_A_ADNA1382_1 (HEAT SHOCK COGNATE 71 KDA PROTEIN)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	6 / 10	GLY A 254 GLY A 255 LYS A 296 SER A 300 SER A 365 ILE A 368	None ANP A 408 (-3.4A) ANP A 408 (-3.1A) ANP A 408 (-2.6A) ANP A 408 (-3.9A) ANP A 408 (-4.8A)	1.33A	5aqfA-3ldoA: 53.7	5aqfA-3ldoA: 69.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AQF_A_ADNA1382_1 (HEAT SHOCK COGNATE 71 KDA PROTEIN)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	7 / 10	GLY A 255 GLU A 293 LYS A 296 SER A 300 SER A 365 ARG A 367 ILE A 368	ANP A 408 (-3.4A) ANP A 408 (-2.5A) ANP A 408 (-3.1A) ANP A 408 (-2.6A) ANP A 408 (-3.9A) ANP A 408 (-4.9A) ANP A 408 (-4.8A)	0.84A	5aqfA-3ldoA: 53.7	5aqfA-3ldoA: 69.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AQF_C_ADNC1382_1 (HEAT SHOCK COGNATE 71 KDA PROTEIN)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	6 / 10	GLY A 226 GLY A 255 LYS A 296 SER A 300 ARG A 367 ILE A 368	ANP A 408 (-3.4A) ANP A 408 (-3.4A) ANP A 408 (-3.1A) ANP A 408 (-2.6A) ANP A 408 (-4.9A) ANP A 408 (-4.8A)	1.15A	5aqfC-3ldoA: 53.3	5aqfC-3ldoA: 69.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AQF_C_ADNC1382_1 (HEAT SHOCK COGNATE 71 KDA PROTEIN)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	7 / 10	GLY A 226 GLY A 255 LYS A 296 SER A 300 GLY A 364 SER A 365 ILE A 368	ANP A 408 (-3.4A) ANP A 408 (-3.4A) ANP A 408 (-3.1A) ANP A 408 (-2.6A) ANP A 408 (-3.1A) ANP A 408 (-3.9A) ANP A 408 (-4.8A)	1.05A	5aqfC-3ldoA: 53.3	5aqfC-3ldoA: 69.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AQF_C_ADNC1382_1 (HEAT SHOCK COGNATE 71 KDA PROTEIN)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	8 / 10	GLY A 227 GLY A 255 GLU A 293 LYS A 296 SER A 300 GLY A 364 SER A 365 ILE A 368	ANP A 408 (-3.4A) ANP A 408 (-3.4A) ANP A 408 (-2.5A) ANP A 408 (-3.1A) ANP A 408 (-2.6A) ANP A 408 (-3.1A) ANP A 408 (-3.9A) ANP A 408 (-4.8A)	0.52A	5aqfC-3ldoA: 53.3	5aqfC-3ldoA: 69.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AQF_C_ADNC1382_1 (HEAT SHOCK COGNATE 71 KDA PROTEIN)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 10	GLY A 227 GLY A 255 GLY A 364 SER A 365 ILE A 371	ANP A 408 (-3.4A) ANP A 408 (-3.4A) ANP A 408 (-3.1A) ANP A 408 (-3.9A) None	0.98A	5aqfC-3ldoA: 53.3	5aqfC-3ldoA: 69.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AQF_C_ADNC1382_1 (HEAT SHOCK COGNATE 71 KDA PROTEIN)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	6 / 10	GLY A 254 GLY A 255 LYS A 296 SER A 300 SER A 365 ILE A 368	None ANP A 408 (-3.4A) ANP A 408 (-3.1A) ANP A 408 (-2.6A) ANP A 408 (-3.9A) ANP A 408 (-4.8A)	1.33A	5aqfC-3ldoA: 53.3	5aqfC-3ldoA: 69.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AQF_C_ADNC1382_1 (HEAT SHOCK COGNATE 71 KDA PROTEIN)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	6 / 10	GLY A 255 GLU A 293 LYS A 296 SER A 300 ARG A 367 ILE A 368	ANP A 408 (-3.4A) ANP A 408 (-2.5A) ANP A 408 (-3.1A) ANP A 408 (-2.6A) ANP A 408 (-4.9A) ANP A 408 (-4.8A)	0.88A	5aqfC-3ldoA: 53.3	5aqfC-3ldoA: 69.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AQY_A_ADNA1389_1 (HEAT SHOCK 70 KDA PROTEIN 1A)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	7 / 10	GLY A 226 GLY A 255 LYS A 296 SER A 300 GLY A 364 SER A 365 ILE A 368	ANP A 408 (-3.4A) ANP A 408 (-3.4A) ANP A 408 (-3.1A) ANP A 408 (-2.6A) ANP A 408 (-3.1A) ANP A 408 (-3.9A) ANP A 408 (-4.8A)	1.02A	5aqyA-3ldoA: 56.3	5aqyA-3ldoA: 66.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AQY_A_ADNA1389_1 (HEAT SHOCK 70 KDA PROTEIN 1A)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	8 / 10	GLY A 227 GLY A 255 GLU A 293 LYS A 296 SER A 300 GLY A 364 SER A 365 ILE A 368	ANP A 408 (-3.4A) ANP A 408 (-3.4A) ANP A 408 (-2.5A) ANP A 408 (-3.1A) ANP A 408 (-2.6A) ANP A 408 (-3.1A) ANP A 408 (-3.9A) ANP A 408 (-4.8A)	0.53A	5aqyA-3ldoA: 56.3	5aqyA-3ldoA: 66.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AQY_A_ADNA1389_1 (HEAT SHOCK 70 KDA PROTEIN 1A)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 10	GLY A 227 GLY A 255 GLY A 364 SER A 365 ILE A 371	ANP A 408 (-3.4A) ANP A 408 (-3.4A) ANP A 408 (-3.1A) ANP A 408 (-3.9A) None	0.99A	5aqyA-3ldoA: 56.3	5aqyA-3ldoA: 66.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AQY_A_ADNA1389_1 (HEAT SHOCK 70 KDA PROTEIN 1A)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	6 / 10	GLY A 254 GLY A 255 LYS A 296 SER A 300 SER A 365 ILE A 368	None ANP A 408 (-3.4A) ANP A 408 (-3.1A) ANP A 408 (-2.6A) ANP A 408 (-3.9A) ANP A 408 (-4.8A)	1.35A	5aqyA-3ldoA: 56.3	5aqyA-3ldoA: 66.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5AQY_A_ADNA1389_1 (HEAT SHOCK 70 KDA PROTEIN 1A)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	7 / 10	GLY A 255 GLU A 293 LYS A 296 SER A 300 SER A 365 ARG A 367 ILE A 368	ANP A 408 (-3.4A) ANP A 408 (-2.5A) ANP A 408 (-3.1A) ANP A 408 (-2.6A) ANP A 408 (-3.9A) ANP A 408 (-4.9A) ANP A 408 (-4.8A)	0.86A	5aqyA-3ldoA: 56.3	5aqyA-3ldoA: 66.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X24_A_LSNA502_1 (CYTOCHROME P450 2C9)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	5 / 12	ALA A 204 VAL A 400 VAL A 50 GLY A 43 THR A 156	None	1.22A	5x24A-3ldoA: undetectable	5x24A-3ldoA: 22.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6C71_B_NCTB501_1 (AMINE OXIDASE)	3ldo	78 KDA GLUCOSE-REGULATED PROTEIN (Homo sapiens)	4 / 8	LEU A 161 TYR A 160 GLU A 51 THR A 29	None	1.01A	6c71B-3ldoA: undetectable	6c71B-3ldoA: 12.50

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1GFZ_A_CFFA940_1","GLYCOGEN PHOSPHORYLASE","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"ASN A 177;PHE A 176;ALA A 179;GLY A 100","None","1.09A","1gfzA-3ldoA:undetectable","1gfzA-3ldoA:18.35"],["1KIA_B_SAMB1293_1","GLYCINE N-METHYLTRANSFERASE","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"ARG A 261;ASP A 250;ASN A 248;SER A 337","None","1.14A","1kiaB-3ldoA:undetectable","1kiaB-3ldoA:21.97"],["1KIA_C_SAMC2293_1","GLYCINE N-METHYLTRANSFERASE","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"ARG A 261;ASP A 250;ASN A 248;SER A 337","None","1.16A","1kiaC-3ldoA:undetectable","1kiaC-3ldoA:21.97"],["1L5Q_A_CFFA863_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"ASN A 177;PHE A 176;ALA A 179;GLY A 100","None","1.10A","1l5qA-3ldoA:undetectable","1l5qA-3ldoA:18.90"],["1L7X_A_CFFA863_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"ASN A 177;PHE A 176;ALA A 179;GLY A 100","None","1.06A","1l7xA-3ldoA:undetectable","1l7xA-3ldoA:18.90"],["1L7X_B_CFFB1863_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"ASN A 177;PHE A 176;ALA A 179;GLY A 100","None","1.09A","1l7xB-3ldoA:undetectable","1l7xB-3ldoA:18.90"],["1NBH_B_SAMB1293_1","GLYCINE N-METHYLTRANSFERASE","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"ARG A 261;ASP A 250;ASN A 248;SER A 337","None","1.14A","1nbhB-3ldoA:1.2","1nbhB-3ldoA:21.97"],["1RJD_B_SAMB802_0","CARBOXY METHYL TRANSFERASE FOR PROTEIN PHOSPHATASE 2A CATALYTIC SUBUNIT","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"ILE A 371;GLY A 254;GLY A 227;LEU A 334;LEU A 253","None;None;ANP A 408 (-3.4A);None;None","1.10A","1rjdB-3ldoA:undetectable","1rjdB-3ldoA:21.88"],["1RJD_C_SAMC803_0","CARBOXY METHYL TRANSFERASE FOR PROTEIN PHOSPHATASE 2A CATALYTIC SUBUNIT","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"ILE A 371;GLY A 254;GLY A 227;LEU A 334;LEU A 253","None;None;ANP A 408 (-3.4A);None;None","1.09A","1rjdC-3ldoA:undetectable","1rjdC-3ldoA:21.88"],["2AVV_A_MK1A901_2","POL POLYPROTEIN","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",3,"ASP A 357;VAL A 360;PRO A 202","None","0.74A","2avvA-3ldoA:undetectable","2avvA-3ldoA:15.10"],["2PIW_A_T3A932_1","ANDROGEN RECEPTOR","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"LEU A  98;VAL A 108;ILE A 112;ILE A 128","None","0.86A","2piwA-3ldoA:undetectable","2piwA-3ldoA:20.05"],["2Q6O_B_SAMB500_0","HYPOTHETICAL PROTEIN","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"ASP A 224;VAL A 362;PRO A 173;THR A 171","None","1.27A","2q6oB-3ldoA:undetectable","2q6oB-3ldoA:23.38"],["3BCR_A_AZZA940_1","GLYCOGEN PHOSPHORYLASE, MUSCLE FORM","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"ASN A 177;PHE A 176;ALA A 179;GLY A 100","None","1.14A","3bcrA-3ldoA:undetectable","3bcrA-3ldoA:18.35"],["3DD1_A_CFFA903_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"ASN A 177;PHE A 176;ALA A 179;GLY A 100","None","1.12A","3dd1A-3ldoA:undetectable","3dd1A-3ldoA:18.99"],["3DD1_B_CFFB903_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"ASN A 177;PHE A 176;ALA A 179;GLY A 100","None","1.09A","3dd1B-3ldoA:undetectable","3dd1B-3ldoA:18.99"],["3DDS_A_CFFA904_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"ASN A 177;PHE A 176;ALA A 179;GLY A 100","None","1.11A","3ddsA-3ldoA:undetectable","3ddsA-3ldoA:18.99"],["3DDS_B_CFFB903_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"ASN A 177;PHE A 176;ALA A 179;GLY A 100","None","1.09A","3ddsB-3ldoA:undetectable","3ddsB-3ldoA:18.99"],["3DDW_A_CFFA903_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"ASN A 177;PHE A 176;ALA A 179;GLY A 100","None","1.12A","3ddwA-3ldoA:undetectable","3ddwA-3ldoA:18.99"],["3DDW_B_CFFB903_1","GLYCOGEN PHOSPHORYLASE, LIVER FORM","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"ASN A 177;PHE A 176;ALA A 179;GLY A 100","None","1.11A","3ddwB-3ldoA:undetectable","3ddwB-3ldoA:18.99"],["3HUO_B_PNNB301_0","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"GLY A 363;GLY A 364;GLY A 255;ASP A 257;ARG A 297","ANP A 408 (-3.2A);ANP A 408 (-3.1A);ANP A 408 (-3.4A);None;None","0.98A","3huoB-3ldoA:undetectable","3huoB-3ldoA:22.86"],["3W9T_D_W9TD507_1","HEMOLYTIC LECTIN CEL-III","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"ASP A 257;GLU A 256;GLY A 228;ASP A 250","None;None;ANP A 408 (-3.6A);None","1.39A","3w9tD-3ldoA:undetectable","3w9tD-3ldoA:20.36"],["3W9T_D_W9TD507_1","HEMOLYTIC LECTIN CEL-III","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"GLU A 316;GLY A 315;TYR A 313;ASP A 281","None","1.20A","3w9tD-3ldoA:undetectable","3w9tD-3ldoA:20.36"],["4K50_A_ACTA506_0","RNA POLYMERASE 3D-POL","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",3,"VAL A  66;GLY A  77;LYS A  81","None","0.73A","4k50A-3ldoA:undetectable","4k50A-3ldoA:22.38"],["4K50_I_ACTI504_0","RNA POLYMERASE 3D-POL","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",3,"VAL A  66;GLY A  77;LYS A  81","None","0.71A","4k50I-3ldoA:undetectable","4k50I-3ldoA:22.38"],["4MM4_B_8PRB603_1","TRANSPORTER","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"ASP A 231;ALA A 206;VAL A 360;SER A 233;THR A 171","None","1.13A","4mm4B-3ldoA:undetectable","4mm4B-3ldoA:21.89"],["4OKW_A_198A1001_1","ANDROGEN RECEPTOR","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"GLY A  58;ARG A 290;THR A 156;ILE A  53;VAL A  42","None","1.34A","4okwA-3ldoA:undetectable","4okwA-3ldoA:19.58"],["4QWP_B_GCSB307_1","CHITOSANASE","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"GLU A 201;THR A  37;GLY A  36;THR A  38","None;ANP A 408 (-3.4A);ANP A 408 (-3.2A);ANP A 408 (-2.8A)","0.95A","4qwpB-3ldoA:undetectable","4qwpB-3ldoA:23.00"],["4Z4G_A_IPHA903_0","PROTEIN ARGONAUTE-2","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"LEU A  98;LYS A 125;PRO A 126;GLU A 143","None","1.14A","4z4gA-3ldoA:6.4","4z4gA-3ldoA:18.18"],["5AQF_A_ADNA1382_1","HEAT SHOCK COGNATE 71 KDA PROTEIN","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",7,"GLY A 226;GLY A 255;LYS A 296;SER A 300;GLY A 364;SER A 365;ILE A 368","ANP A 408 (-3.4A);ANP A 408 (-3.4A);ANP A 408 (-3.1A);ANP A 408 (-2.6A);ANP A 408 (-3.1A);ANP A 408 (-3.9A);ANP A 408 (-4.8A)","1.04A","5aqfA-3ldoA:53.7","5aqfA-3ldoA:69.33"],["5AQF_A_ADNA1382_1","HEAT SHOCK COGNATE 71 KDA PROTEIN","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",7,"GLY A 226;GLY A 255;LYS A 296;SER A 300;SER A 365;ARG A 367;ILE A 368","ANP A 408 (-3.4A);ANP A 408 (-3.4A);ANP A 408 (-3.1A);ANP A 408 (-2.6A);ANP A 408 (-3.9A);ANP A 408 (-4.9A);ANP A 408 (-4.8A)","1.14A","5aqfA-3ldoA:53.7","5aqfA-3ldoA:69.33"],["5AQF_A_ADNA1382_1","HEAT SHOCK COGNATE 71 KDA PROTEIN","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",8,"GLY A 227;GLY A 255;GLU A 293;LYS A 296;SER A 300;GLY A 364;SER A 365;ILE A 368","ANP A 408 (-3.4A);ANP A 408 (-3.4A);ANP A 408 (-2.5A);ANP A 408 (-3.1A);ANP A 408 (-2.6A);ANP A 408 (-3.1A);ANP A 408 (-3.9A);ANP A 408 (-4.8A)","0.52A","5aqfA-3ldoA:53.7","5aqfA-3ldoA:69.33"],["5AQF_A_ADNA1382_1","HEAT SHOCK COGNATE 71 KDA PROTEIN","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"GLY A 227;GLY A 255;GLY A 364;SER A 365;ILE A 371","ANP A 408 (-3.4A);ANP A 408 (-3.4A);ANP A 408 (-3.1A);ANP A 408 (-3.9A);None","0.99A","5aqfA-3ldoA:53.7","5aqfA-3ldoA:69.33"],["5AQF_A_ADNA1382_1","HEAT SHOCK COGNATE 71 KDA PROTEIN","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",6,"GLY A 254;GLY A 255;LYS A 296;SER A 300;SER A 365;ILE A 368","None;ANP A 408 (-3.4A);ANP A 408 (-3.1A);ANP A 408 (-2.6A);ANP A 408 (-3.9A);ANP A 408 (-4.8A)","1.33A","5aqfA-3ldoA:53.7","5aqfA-3ldoA:69.33"],["5AQF_A_ADNA1382_1","HEAT SHOCK COGNATE 71 KDA PROTEIN","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",7,"GLY A 255;GLU A 293;LYS A 296;SER A 300;SER A 365;ARG A 367;ILE A 368","ANP A 408 (-3.4A);ANP A 408 (-2.5A);ANP A 408 (-3.1A);ANP A 408 (-2.6A);ANP A 408 (-3.9A);ANP A 408 (-4.9A);ANP A 408 (-4.8A)","0.84A","5aqfA-3ldoA:53.7","5aqfA-3ldoA:69.33"],["5AQF_C_ADNC1382_1","HEAT SHOCK COGNATE 71 KDA PROTEIN","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",6,"GLY A 226;GLY A 255;LYS A 296;SER A 300;ARG A 367;ILE A 368","ANP A 408 (-3.4A);ANP A 408 (-3.4A);ANP A 408 (-3.1A);ANP A 408 (-2.6A);ANP A 408 (-4.9A);ANP A 408 (-4.8A)","1.15A","5aqfC-3ldoA:53.3","5aqfC-3ldoA:69.33"],["5AQF_C_ADNC1382_1","HEAT SHOCK COGNATE 71 KDA PROTEIN","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",7,"GLY A 226;GLY A 255;LYS A 296;SER A 300;GLY A 364;SER A 365;ILE A 368","ANP A 408 (-3.4A);ANP A 408 (-3.4A);ANP A 408 (-3.1A);ANP A 408 (-2.6A);ANP A 408 (-3.1A);ANP A 408 (-3.9A);ANP A 408 (-4.8A)","1.05A","5aqfC-3ldoA:53.3","5aqfC-3ldoA:69.33"],["5AQF_C_ADNC1382_1","HEAT SHOCK COGNATE 71 KDA PROTEIN","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",8,"GLY A 227;GLY A 255;GLU A 293;LYS A 296;SER A 300;GLY A 364;SER A 365;ILE A 368","ANP A 408 (-3.4A);ANP A 408 (-3.4A);ANP A 408 (-2.5A);ANP A 408 (-3.1A);ANP A 408 (-2.6A);ANP A 408 (-3.1A);ANP A 408 (-3.9A);ANP A 408 (-4.8A)","0.52A","5aqfC-3ldoA:53.3","5aqfC-3ldoA:69.33"],["5AQF_C_ADNC1382_1","HEAT SHOCK COGNATE 71 KDA PROTEIN","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"GLY A 227;GLY A 255;GLY A 364;SER A 365;ILE A 371","ANP A 408 (-3.4A);ANP A 408 (-3.4A);ANP A 408 (-3.1A);ANP A 408 (-3.9A);None","0.98A","5aqfC-3ldoA:53.3","5aqfC-3ldoA:69.33"],["5AQF_C_ADNC1382_1","HEAT SHOCK COGNATE 71 KDA PROTEIN","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",6,"GLY A 254;GLY A 255;LYS A 296;SER A 300;SER A 365;ILE A 368","None;ANP A 408 (-3.4A);ANP A 408 (-3.1A);ANP A 408 (-2.6A);ANP A 408 (-3.9A);ANP A 408 (-4.8A)","1.33A","5aqfC-3ldoA:53.3","5aqfC-3ldoA:69.33"],["5AQF_C_ADNC1382_1","HEAT SHOCK COGNATE 71 KDA PROTEIN","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",6,"GLY A 255;GLU A 293;LYS A 296;SER A 300;ARG A 367;ILE A 368","ANP A 408 (-3.4A);ANP A 408 (-2.5A);ANP A 408 (-3.1A);ANP A 408 (-2.6A);ANP A 408 (-4.9A);ANP A 408 (-4.8A)","0.88A","5aqfC-3ldoA:53.3","5aqfC-3ldoA:69.33"],["5AQY_A_ADNA1389_1","HEAT SHOCK 70 KDA PROTEIN 1A","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",7,"GLY A 226;GLY A 255;LYS A 296;SER A 300;GLY A 364;SER A 365;ILE A 368","ANP A 408 (-3.4A);ANP A 408 (-3.4A);ANP A 408 (-3.1A);ANP A 408 (-2.6A);ANP A 408 (-3.1A);ANP A 408 (-3.9A);ANP A 408 (-4.8A)","1.02A","5aqyA-3ldoA:56.3","5aqyA-3ldoA:66.24"],["5AQY_A_ADNA1389_1","HEAT SHOCK 70 KDA PROTEIN 1A","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",8,"GLY A 227;GLY A 255;GLU A 293;LYS A 296;SER A 300;GLY A 364;SER A 365;ILE A 368","ANP A 408 (-3.4A);ANP A 408 (-3.4A);ANP A 408 (-2.5A);ANP A 408 (-3.1A);ANP A 408 (-2.6A);ANP A 408 (-3.1A);ANP A 408 (-3.9A);ANP A 408 (-4.8A)","0.53A","5aqyA-3ldoA:56.3","5aqyA-3ldoA:66.24"],["5AQY_A_ADNA1389_1","HEAT SHOCK 70 KDA PROTEIN 1A","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"GLY A 227;GLY A 255;GLY A 364;SER A 365;ILE A 371","ANP A 408 (-3.4A);ANP A 408 (-3.4A);ANP A 408 (-3.1A);ANP A 408 (-3.9A);None","0.99A","5aqyA-3ldoA:56.3","5aqyA-3ldoA:66.24"],["5AQY_A_ADNA1389_1","HEAT SHOCK 70 KDA PROTEIN 1A","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",6,"GLY A 254;GLY A 255;LYS A 296;SER A 300;SER A 365;ILE A 368","None;ANP A 408 (-3.4A);ANP A 408 (-3.1A);ANP A 408 (-2.6A);ANP A 408 (-3.9A);ANP A 408 (-4.8A)","1.35A","5aqyA-3ldoA:56.3","5aqyA-3ldoA:66.24"],["5AQY_A_ADNA1389_1","HEAT SHOCK 70 KDA PROTEIN 1A","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",7,"GLY A 255;GLU A 293;LYS A 296;SER A 300;SER A 365;ARG A 367;ILE A 368","ANP A 408 (-3.4A);ANP A 408 (-2.5A);ANP A 408 (-3.1A);ANP A 408 (-2.6A);ANP A 408 (-3.9A);ANP A 408 (-4.9A);ANP A 408 (-4.8A)","0.86A","5aqyA-3ldoA:56.3","5aqyA-3ldoA:66.24"],["5X24_A_LSNA502_1","CYTOCHROME P450 2C9","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",5,"ALA A 204;VAL A 400;VAL A  50;GLY A  43;THR A 156","None","1.22A","5x24A-3ldoA:undetectable","5x24A-3ldoA:22.54"],["6C71_B_NCTB501_1","AMINE OXIDASE","3ldo","78 KDA GLUCOSE-REGULATED PROTEIN","Homo sapiens",4,"LEU A 161;TYR A 160;GLU A  51;THR A  29","None","1.01A","6c71B-3ldoA:undetectable","6c71B-3ldoA:12.50"]]